OR
ORIC Pharmaceuticals, Inc.
ORIC · NASDAQ
$12.86 +2.80% (+$0.35)
1M -5.58%
Market Cap $1.33B
P/E Ratio -
Div. Yield -
ROE 35.35%
Bulios Fair Price
$8.67
32.6% downside
Trenutna cena
$12.86
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ORIC trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
58 /100
Fair P/B 3.49x
EV/FFO N/A
P/E N/A
Growth
100 /100
Growing Book val. growth 20.01%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 34.68%
ROIC 40.32%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 13.19x
Debt/Equity 0.01x
Debt/Assets N/A
Stability
76 /100
Stable Profitable years 0
Beta 0.99x
EPS volatility 6.52%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ORIC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jacob Chacko
Employees
111
Headquarters
South San Francisco
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report